MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-33-0227980
Humanlife Pharmaceuticals Private Limited
Humanlife Pharmaceuticals Private Limited - chemicals in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹53.28 Lakh
▼ 18% YoY
Net profit · FY 2025
₹5.05 Lakh
Net margin 9.5%
EBITDA · FY 2025
₹7.13 Lakh
EBITDA margin 13.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Humanlife Pharmaceuticals Private Limited
Data last updated:
Humanlife Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 August 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2016PTC284610. Its GSTIN is 08AADCH9491E1ZB (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Saurabh Jain and Usha Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.28 Lakh, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹5.05 Lakh (net margin 9.5%) and EBITDA of ₹7.13 Lakh (EBITDA margin 13.4%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
Humanlife Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0227980). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24230MH2016PTC284610
Registration Number 284610
Incorporation Date 09 August 2016
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0227980
Key People
Saurabh Jain Director Usha Jain Director Recognitions & Rankings of Humanlife Pharmaceuticals
Contact details
Humanlife Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Gaurav Luhadiya S/O Kanti Kumar Luhadiya C – 102 Rustomjee Athena Majiwada Thane, West, Mumbai, Maharashtra, India – 400601
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Humanlife Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Humanlife Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Humanlife Pharmaceuticals is human health and social work activities. In detail, this covers human health activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Human health and social work activities | 86 | Human health activities |
To see the full business activity and turnover split of Humanlife Pharmaceuticals Private Limited, buy the company report.
Financials of Humanlife Pharmaceuticals Private Limited
FY 2025 filings availableHumanlife Pharmaceuticals Private Limited reported revenue of ₹53.28 Lakh (down 18% YoY) for FY 2025.
Revenue · FY 2025
₹53.28 Lakh ▼ 18%
Net profit · FY 2025
₹5.05 Lakh margin 9.5%
EBITDA · FY 2025
₹7.13 Lakh margin 13.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 18%
3 years · compounded
▲ 7%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▼ 37%
3 years · compounded
▲ 3%
5 years · compounded
▲ 24%
Revenue fell 18% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 37% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.13 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.05 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.4% | ||||
| Net Profit Margin | 9.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Humanlife Pharmaceuticals Private Limited, buy the company report.
Board of directors of Humanlife Pharmaceuticals Private Limited
Humanlife Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Jain | Director | 19 Jul 2021 | 5 Years 3 Months | Current |
| Usha Jain | Director | 09 Aug 2016 | 10 Years 2 Months | Current |
Shareholding
The shareholding of Humanlife Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Humanlife Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Humanlife Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Humanlife Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Humanlife Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AADCH9491E1ZB | Rajasthan | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Humanlife Pharmaceuticals Private Limited, buy the company report.
Recent activity
Humanlife Pharmaceuticals Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Sushila Devi ceased to be Director on 10 Feb 2024.
AGM
Humanlife Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Humanlife Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Ceased
Sushila Devi ceased to be Director.
Ceased
Saurabh Jain ceased to be Additional Director.
Ceased
Rohit Kumar ceased to be Director.
Appointed
Saurabh Jain was appointed as Director.
Appointed
Usha Jain was appointed as Director.
Incorporation
09 Aug 2016
Humanlife Pharmaceuticals Private Limited was registered on 09 Aug 2016 with Roc Mumbai I & aged 10 years 2 months as per MCA records.
Frequently asked questions
Humanlife Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 August 2016 (10+ years old) and is registered under CIN U24230MH2016PTC284610.
Humanlife Pharmaceuticals has 2 current directors:
- Saurabh Jain - Director
- Usha Jain - Director
The latest financial statements of Humanlife Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Humanlife Pharmaceuticals is 08AADCH9491E1ZB, registered in Rajasthan.
The CIN (Corporate Identification Number) of Humanlife Pharmaceuticals is U24230MH2016PTC284610. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Humanlife Pharmaceuticals was incorporated on 09 August 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
Sushila Devi ceased to be Director on 10 Feb 2024. Saurabh Jain ceased to be Additional Director on 30 Nov 2021. Rohit Kumar ceased to be Director on 29 Nov 2021. Humanlife Pharmaceuticals has 5 board changes on record in total.
Yes, Humanlife Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0227980).
The registered office of Humanlife Pharmaceuticals is at CO Gaurav Luhadiya SO Kanti Kumar Luhadiya C – 102 Rustomjee Athena Majiwada Thane, West, Mumbai, Maharashtra, India – 400601.
Humanlife Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.